As of November 6, 2026, Chemomab Therapeutics Ltd. is a publicly traded company (Nasdaq: CMMB). The largest holder reporting an active stake on Schedule 13D is HBM Healthcare Investments (Cayman) Ltd., at 12.5%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Morgan Stanley (8.4%), Touchstone Global Investments Pty Ltd (5.2%) (Schedule 13D/A, September 9, 2026).
Is this your company?
About to sign with, pay or invest in Chemomab Therapeutics Ltd.? See the free Snapshot first.
Free to see. No signup.
Is Chemomab Therapeutics Ltd. a real, registered company?
- Chemomab Therapeutics Ltd. files with the SEC under CIK 1534248 (its SEC filings).
- Its shares are listed under the ticker CMMB on Nasdaq (SEC company record).
- Incorporated in L3, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Chemomab Therapeutics Ltd. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names HBM Healthcare Investments (Cayman) Ltd. (filed 2026-09-09).
Who are Chemomab Therapeutics Ltd.'s owners and officers?
Chemomab Therapeutics Ltd.: industry Pharmaceutical Preparations (Schedule 13D/A, 2026-09-09).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2024-08-09)
- : Executive Officer (Form D, 2024-08-09)
- : Executive Officer (Form D, 2024-08-09)
- : Director (Form D, 2024-08-09)
- : Director (Form D, 2024-08-09)
- : Director (Form D, 2024-08-09)
- : Director (Form D, 2024-08-09)
- : Director (Form D, 2024-08-09)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-09-09 | Hbm Healthcare Investments (Cayman) LTD. | 12.5% |
| Schedule 13G, 2026-08-13 | Touchstone Global Investments Pty LTD | 5.2% |
| Schedule 13G/A, 2026-08-10 | Otto Erik | 1.2% |
| Schedule 13D, 2026-07-16 | Hbm Healthcare Investments (Cayman) LTD. | 12.5% |
| Schedule 13G/A, 2026-02-17 | Peter Thiel | 4.6% |
| Schedule 13G/A, 2026-02-10 | Otto Erik | 6.3% |
| Schedule 13G/A, 2025-08-11 | Otto Erik | 8.1% |
| Schedule 13G, 2025-08-07 | Morgan Stanley | 8.4% |
| Schedule 13G/A, 2025-08-07 | Morgan Stanley | 3.2% |
Questions about who owns Chemomab Therapeutics Ltd.
Who owns Chemomab Therapeutics Ltd.?
On this page, 3 holders' latest ownership filings report 5% or more of Chemomab Therapeutics Ltd.: Hbm Healthcare Investments (Cayman) LTD. (12.5%, Schedule 13D/A, filed 2026-09-09), Morgan Stanley (8.4%, Schedule 13G, filed 2025-08-07) and Touchstone Global Investments Pty LTD (5.2%, Schedule 13G, filed 2026-08-13).
Who are the largest shareholders of Chemomab Therapeutics Ltd.?
By the share each holder's latest filing reports, the largest holders of Chemomab Therapeutics Ltd. on this page are Hbm Healthcare Investments (Cayman) LTD. (12.5%), Morgan Stanley (8.4%) and Touchstone Global Investments Pty LTD (5.2%).
When did Hbm Healthcare Investments (Cayman) LTD. buy into Chemomab Therapeutics Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Hbm Healthcare Investments (Cayman) LTD. on this page is the Schedule 13D, filed 2026-07-16, reporting 12.5%; its latest, Schedule 13D/A filed 2026-09-09, reports 12.5%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Chemomab Therapeutics Ltd.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Chemomab Therapeutics Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Chemomab Therapeutics Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Chemomab Therapeutics Ltd. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 33,000 shares (0.01% of shares outstanding) (Form 4, 2026-09-01).
- , the chief development officer: 20,000 shares (0.00% of shares outstanding) (Form 3, 2026-04-10).
- , the chief executive and a director: 18,750 shares (0.00% of shares outstanding) (Form 4, 2026-06-01).
- , the chief financial officer: 12,500 shares (0.00% of shares outstanding) (Form 3, 2026-04-10).
- , a director: 300 shares (0.00% of shares outstanding) (Form 3, 2026-04-10).
Shares outstanding: 575,381,320 as of 2025-12-31, from the company's latest SEC cover page.
How much has Chemomab Therapeutics Ltd. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-08-09 | $10M | $10M |
Keep reading
More on Chemomab Therapeutics Ltd. and the records around it.
Chemomab Therapeutics Ltd. elsewhere on the record
- 5%+ stake filings Sep 2026
Companies that share a holder
- HBM Healthcare Investments (Cayman) Ltd. also filed stake reports on 7 other companies: ALX ONCOLOGY HOLDINGS INC (May 2026), IO Biotech, Inc. (Apr 2026), Upstream Bio, Inc. (Nov 2025)
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (Oct 2026), Arbutus Biopharma Corp (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/chemomab-therapeutics